PMK-Group, operating through PMK Ventures, focuses on fueling innovation in the Biotech and MedTech sectors. They provide strategic capital and expertise to early-stage companies worldwide, empowering them to advance healthcare solutions. Their mission is to guide groundbreaking ideas from concept to market by providing capital, service, mentorship, and networks to navigate the complex clinical R&D process. The firm recognizes the challenges in bringing life-saving innovations to market, including high costs, long timelines, and regulatory hurdles. They aim to de-risk projects by providing tailored funding, clinical R&D guidance, and access to a global network. This includes helping portfolio companies navigate clinical trials, access regulatory and scientific expertise, and make strategic hires and exits. PMK-Ventures targets early-stage Biotech & MedTech companies committed to long-term value creation, not just quick wins. They are based in Singapore with a global outlook. The firm is backed by experts in clinical development, regulation, and commercialization. They invest strategically with a company's roadmap in mind. PMK-Group aims to be more than just a source of capital; they provide ongoing professional support and de-risking, making them a unique partner in the healthcare innovation space.
Preferred startup development maturity for initial funding deployment.
Biotech, MedTech, CNS Diseases, Neuroinflammation, Disease Modifying Therapies, Aging, Neurodegenerative Diseases, Mental & Emotional Wellbeing, Brain Health, Migraine Prophylaxis, Early Disease Detection, Neurology, Longevity, Women's Health, Oncology Diagnostics
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...